Get your free ETF data sample from our comprehensive offerings. Start your free trial→

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

›ETF Issuers›Harbor Capital›MEDI
MEDI

Harbor Health Care ETF

Active ETFEquity
Not rated

The MEDI Exchange Traded Fund (ETF) is provided by Harbor Capital. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$34.23
-$0.013 (-0.04%) yesterday
1:30 PM 09/01/26 Closed
1D price range
$34.10$34.40
52W price range
$27.50$35.61
YTD Perf.
+8.81%
YTD Flows
Annualized volatility
Fund AuM
€38M
Share class AuM
€38M
TTM Yield
Tracking Error
Tracking Difference
Characteristics
ISIN
US41151J8696
TER
0.8%
Inception date
11/16/2022
Issuer
Harbor Capital
Dividend policy
Distributing
Compare similar ETFs
ETF Name1w perf.
WELL
Harbor Health Care UCITS ETF
-1.40%
GDOC
Goldman Sachs Future Health Care Equity ETF
-2.38%
API
PerformanceDec 31, 2025 - Aug 31, 2026
-10%-5%0%5%10%JANMARMAYJUL
Flows
Join for free to unlock
Sector exposures
Data as of 07/31/26
Healthcare
85.43%
Unavailable
14.57%
Latest MEDI news

No content available for this fund

FAQ about MEDI

MEDI is a Active ETF. This ETF provides exposure to Other Health Care Equities.
MEDI carries a total expense ratio (TER) of 0.8%, indicating the annual cost for holding the fund.
MEDI was introduced to the market on November 16, 2022. It trades on United States
Harbor Health Care ETF, MEDI, is provided by Harbor Capital. Learn more about Harbor Capital here.
MEDI oversees €38M in assets as of August 31, 2026.
MEDI follows a distributing dividend policy, meaning it pays out income to investors. As of August 31, 2026, its 12-month trailing yield was 0.44%.
As of July 31, 2026, MEDI has significant geographic allocations in USA, Netherlands and France.
As of July 31, 2026, MEDI focuses largely on Healthcare.
As of July 31, 2026, MEDI holds 43 positions in its portfolio, with 70.63% of assets concentrated in its top 15 holdings.
As of July 31, 2026, MEDI top three holdings include Eli Lilly & Co., US04351P1012 and Gilead Sciences, Inc..
The base currency of MEDI is USD.
Top 10 holdings
Data as of 07/31/26
Eli Lilly & Co.
20.56%
US04351P1012
13.79%
Gilead Sciences, Inc.
5.06%
Rhythm Pharmaceuticals, Inc.
4.21%
AbbVie, Inc.
3.12%
Intuitive Surgical, Inc.
2.78%
Cencora, Inc.
2.71%
Revolution Medicines, Inc.
2.56%
Insmed, Inc.
2.55%
Merck & Co., Inc.
2.42%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
ETF TOOLS
ETF ScreenerCompare ETFsCompare ETF issuersWatchlistsETF Portfolio InsightsIndustry dataETF stock exposure finder
PLATFORM
Support and feedback
ETF NEWS & RESEARCH
Latest ETF NewsETF Research ReportsGlobal ETF Survey 2025Learn ETF investing
PROFESSIONAL SOLUTIONS
Enterprise SolutionsDue Diligence ServicesETF Data Services
SOLUTIONS FOR
Institutional investorsPrivate banksFinancial advisorsFintech and mediaIndividual investors
CONTACT US
General inquiries
Press and media
Advertising opportunities
Support and feedback
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Get our newsletters
Trackinsight